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ABSTRACT
DIRECT MEASUREMENT OF FATTY ACID BINDING PROTEIN FROM RAT
LIVER CYTOSOL

Name: Bathula Mridul
University of Dayton

Advisor: Dr. S.S. Singer
Rat liver fatty acid-binding protein (LFABP) is a 14-16 kDa cytosol protein which
binds long chain free fatty acids and is believed to participate in intercellular movement

and distribution of free fatty acids. My studies on LFABP are expected to lead to a direct
assay to quantitate rat LFABP in cytosol. This new direct assay method is designed to

replace our present In-House Method (IHM) of FABP measurement which uses
Sephadex G-75 column chromatography and rose Bengal assay. This direct assay method
will change the IHM from a day-long method to measure LFABP to a procedure that can

be done in ~2 hours. The direct assay method is based upon a fluorescence enhancement

process where LFABP and rose Bengal interactions are exposed to emission of a 543 nm

laser to produce a fluorescence spectrum. The procedure was found specific for
homogeneous LFABP (hLFABP), while potentially interfering components of cytosol,

hemoglobin, myoglobin, and serum albumin, do not fluoresce like hLFABP.
My experimental results indicate that cytosol can be directly used in the direct

assay method to quantitate FABP, and the presence of other potential contaminants in

iii

cytosol, along with FABP, do not interfere/alter the process to measure FABP. My

research shows future promise in replacing the IHM and in the fields of medicine that
are attempting to understand and elucidate cures for lipid- related diseases. Since

LFABP takes part in dietary fatty acid transport from intestine to blood to liver, for
bioenergy production and biosynthesis, any dysfunction of LFABP may cause or be
associated with altered lipid uptake/metabolism. These studies can be extended in
future to quantitate/study other FABPs like intestinal FABP (IFABP) and perhaps be

helpful in making a biosensor for detecting FABP.

IV

ACKNOWLEDGEMENTS

My special thanks are in order to Dr. Sanford S. Singer, my primary research advisor,

who has been a constant source of inspiration to me, who provided the time,

guidance, and equipment necessary for the work contained herein, and for directing
this thesis and bringing it to its conclusion with patience and expertise. I also thank
him for his willingness to share his knowledge and experience with me.

I would also like to express my appreciation to everyone who has helped with the
work. This includes Dr. Jay Johnson, who offered guidance and direction for my
research, Dr. Kevin J. Myers, my academic advisor, who gave advice concerning

academics and curriculum, Dr. Tony E. Saliba, for providing necessary equipment
and financial support for completion of my research and thesis. I also deeply

appreciate the help given by my parents and brother, who guided me and supported
me in all the endeavors.

v

TABLE OF CONTENTS
ABSTRACT................................................................................................iii
ACKNOWLEDGEMENT.......................................................................... v

LIST OF ILLUSTRATIONS.......................................................................vii
LIST OF TABLES....................................................................................... ix
LIST OF SYMBOLS/ABBREVATIONS.................................................... x
CHAPTER
I. INTRODUCTION............................................................................... 1
II. OBJECTIVES...................................................................................... 8

III. MATERIALS AND METHODS.........................................................9

Materials................................................................................... 9
i.

Instruments

ii.

Solutions and chemicals

Routine In-House Method...................................................... 11

i.
ii.

Assay Methods
Calculations

IV. DIRECT ASSAY METHOD.............................................................. 16
Experimental Setup for Direct Assay...................................... 16
Data Plotting and Calculations.................................................17

V. RESULTS.......................................................................................... 20
Rose Bengal............................................................................. 20
Calculations............................................................................ 33

VI. DISCUSSION.................................................................................... 35
VII. CONCLUSION AND RECCOMENDATIONS................................ 40

BIBLIOGRAPHY........................................................................................ 41

vi

LIST OF ILLUSTRATIONS

1. 280 nm Absorbance from A-280 assay................................................ 13
2. A-560 assay indicating the fractions containing FABP...................... 14
3. Experimental setup for the direct assay method.................................. 16

4. Effective emission peak plotted against the FABP

concentration....................................................................................... 19
5. Emission peak of lOmM rose Bengal solution.................................... 20
6. Different concentrations of rose Bengal used to

check the concentration which is best to use....................................... 21
7. Enhanced emission peak due to binding of 9.5mg/mL

LFABP with lOmM rose Bengal solution........................................... 22

8. Effect of different concentrations of LFABP on
the emission peak of lOmM rose Bengal solution............................... 23

9. Effect of 0. lmg/ml BSA on the emission peak
due to lOmM rose Bengal.................................................................... 24
10. Effects of different concentrations of BSA on

the emission peak of lOmM rose Bengal solution............................... 24
11. Effect of lOmg/ml Myoglobin (a) and Hemoglobin (b)
on the emission peak of lOmM rose Bengal....................................... 25

vii

12. Effects of different concentrations of BSA on

the enhanced emission peak due to LFABP....................................... 25
13. Effect of different concentration of LFABP on

the quenched emission peak due to O.lmg/mL BSA........................... 26
14. Effect of different concentration of LFABP on

the quenched emission peak due to lOmg/mL BSA............................ 27
15. Effect of lOmg/mL myoglobin on the enhanced

emission peak due to 9.5mg/ml LFABP.............................................. 27
16. Effect of 9.5 mg/ml LFABP on the quenched emission peak by

10 mg/mL myoglobin.......................................................................... 28
17. Effect of 9.5mg/mL LFABP on the quenched

emission peak due to lOmg/ml hemoglobin......................................... 28
18. Sample Sephadex G-75 Chromatogram from the IHM........................ 30
19. Effect of FABP and non-FABP containing pool on

the emission peak of rose Bengal......................................................... 30

20. Effect of cytosol on the emission peak of 10 mM rose Bengal............ 31

21. Enhanced emission peak of cytosol from animals on different
diets....................................................................................................... 32

22. IHM data (mg FABP/g tissue) plotted against the effective

emission peak height in the direct assay method.................................. 32

viii

LIST OF TABLES

1. Pool Assay to quantitate FABP by IHM........................................ 14

2. Sample emission peak data............................................................. 18

3. FABP concentration against effective emission peak.................... 19
4. Sample calculation of [FABP] from the graph for myoglobin...... 29
5. Effective emission peak height calculated for ImL sample.......... 33
6. Comparison of IHM with direct assay method............................... 34

IX

LIST OF SYMBOLS/ABBREVATIONS

FABP = Fatty Acid Binding Protein
LFABP = Liver Fatty Acid Binding Protein
IFABP = Intestine Fatty Acid Binding Protein

IHM = In-House Method
BSA = Bovine Serum Albumin

LCFA = Long chain fatty acids

TSM = Tris Buffer
mM = millimolar
mg = milligrams

mL = milliliters

g = gram

gL = micro liters
kDa = kilo Daltons

AH° = Standard enthalpy change of reaction
nm = nanometer

x

CHAPTER 1
INTRODUCTION
1.1 Proteins and Chromatography

Proteins are macromolecules which are constructed from one or more unbranched
chains of amino acids. A typical protein contains 200-300 amino acids1. A very common
technique that is used to separate biological molecules is called chromatography.

Different chromatography procedures can be used to separate proteins into individual
components2.

Some common chromatography methods used to separate proteins are partition

chromatography, ion exchange chromatography, and molecular sieve or gel filtration
chromatography2.

In partition chromatography, a mixture of molecules is separated

based upon their relative affinity for two immiscible phases (the mobile phase and the
stationary phase) . Mobile phase is a buffer in which proteins are soluble and stationary

phase is a column of beads containing pores.
Gel filtration chromatography which is used in our “In House Method” (IHM)3,4

uses size differences to separates proteins. In gel filtration chromatography a protein

solution is passed through a column that is packed with semi- permeable porous resin.
The resin has a range of pore sizes that determine the size of protein that can be separated
with the column . This is called the fractionation range or exclusion range of the resin.
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In our IHM a Sephadex G-753’4 porous matrix made of polysaccharide beads
through which the proteins can diffuse is used. It has pores that exclude molecules larger
than 80 kDa". The size of the pores in the matrix determines the rate at which proteins of
various sizes diffuse and pass through the beads. Molecules under 80 kDa can enter the

pores of the beads, which impede the movement of such molecules. The excluded, larger
molecules simply go around the beads. Because these larger proteins are unable to enter

the pores they pass quickly through the column in the spaces between the resin beads and

elute first. Very small proteins and other low molecular weight substances that are below
the exclusion range of the resin enter all the pores in the resin, and move through the
column very slowly because they must pass through the entire volume of the column.
These molecules pass through the end of the chromatogram in a “totally included peak”2.

To separate a protein sample by gel filtration chromatography, the column must
first be equilibrated with the desired buffer. This is accomplished by passing several

column volumes of the buffer through it. Equilibration is an important step because the
equilibration buffer is the buffer in which the protein sample will elute in a bioactive

form. Next, the sample is loaded onto the column and allowed to enter the resin. Then
more of the equilibration buffer is passed through the column to separate the sample and

elute it from the column. Fractions (measured aliquots) are collected as the sample elutes
from the column. Larger proteins elute in the early fractions and smaller proteins elute in
subsequent fractions .

2

FABPs, Their Roles and Significance
The proteins of interest here are fatty acid binding proteins (FABPs). FABPs are
cytosolic proteins that non-covalently bind long-chain fatty acids (LCFA)5. Despite many

years of research, the precise biological function(s) of FABPs remain unclear5,6. The

proposed functions can be summarized as follows: FABPs are involved in facilitating the
uptake and intercellular transport of fatty acids, limiting ligand association with

alternative binding sites within the cell, and modulating cell growth and differentiation5,6.

FABPs were originally classified as Z proteins , a pre-existing class originally
found to be a binding protein for organic anions, fatty acids and aminoazodyes. Because

of the anion-binding activity of rat Z protein, it was initially thought that a single protein
was responsible for all FABP activity7. An early hypothesis was that intracellular FABPs

bind fatty acids in the cytoplasm and thereby prevent their nonspecific detergent effects
on disrupting membrane function. Intracellular FABP levels are in the 0.2 -0.4 mM range

in the tissues active in fatty acid metabolism8.

Several different FABPs have been identified since then, each named after the
tissue in which it was first discovered5,6. These include the heart, epidermis, adipose
tissue, liver, and small intestine1. The amino acid sequences in FABPs exhibit

considerable tissue specific variation9. FABPs are clam shell-shaped proteins consisting
of two antiparallel p-pleated sheets of 5 strands apiece and 2 short a-helices forming the
shell halves10. Rat liver FABPs are most extensively studied. They have a molecular mass
of 14-16 kDa6.
The initial binding of the LCFA to a FABP occurs between the e-amino group on
a FABP lysine residue and the carboxylate of the LCFA10,11. When lipids are digested,
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they are broken down into glycerol and fatty acids, and these fatty acids bind to FABP.

The term fatty acid identifies saturated and unsaturated monobasic carboxylic acids, and
several series of substituted acids having carbon skeletons identical with normal saturated

• exist
-12 . Fatty acids are important source of cellular energy and form the building
acids
blocks from which various cellular components are synthesized13. At least 60% of the

long chain fatty acids found in the liver cytosol are bound to liver FABP12.

My research primarily concerns liver FABP (LFABP) in rats. LFABP is
structurally and functionally different from the other FABP types6. LFABP binds two
fatty acids per molecule, whereas the other FABP types have a single fatty acid binding
site . LFABP may play a role as an intercellular acceptor of LCFA, by enhancing LCFA
uptake and intercellular transport14. Several enzyme activities, especially enzymes
involved in fatty acid metabolism, are stimulated by LFABP14. In contrast, intestinal fatty

acid binding protein (IFABP) functions in the transfer of fatty acids from the intestine to
the bloodstream 15. LFABP binds these free circulating fatty acids as they pass through

the hepatic capillary bed and helps transfer them into liver cells for metabolism15. Thus,

IFABP contributes to plasma fatty acid content while LFABP removes fatty acids from

the bloodstream15,16.
Comparing the primary structure of the liver and intestinal FABPs indicates
significant similarity as well as difference. In the amino-terminal domains there is a high

degree of sequence homology, wherein 11 of the first 22 residues are identical12. The
amino acid sequences exhibit considerable tissue specific variation9. Different FABP

types in one species show amino acid sequence identities ranging from 20 to 70%17.
Affinities, kinetics, and thermodynamics of FA interactions with FABP from different
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tissues are quite different, but these characteristics are quite similar for FABPs from the

same tissue of different species9. For example, while A7/° for adipocyte, heart, intestine,
and liver from oleate binding range from -7 to -12 kcal/mol, single Alanine substitution
in intestine generates proteins with A/A ranging from -4 to -17 kcal/mol9.

LFABP is an abundant protein constituting 5% of the cytosolic mass in the liver,
whereas IFABP constitutes 2.5% of the cytosolic mass in the intestine12. LFABP has the
broadest substance specificity among FABPs studied and has an aqueous diffusion

mediated lipid transfer mechanism which differs from other FABPs17,18. LFABP is a

tumour cell marker in hepatic cell malignancies, colorectal and hepatic carcinomas.

LFABP is useful for detection of liver damage during and after transplantation19,20. The
primary function of soluble binding proteins such as FABP may be to enhance the

diffusive fluxes of their ligands by reducing membrane binding6.
LFABP takes part in dietary fatty acid transport from intestine to blood to liver,
for bioenergy production and biosynthesis. Hence, dysfunction of either FABP or
variation of the ratio of LFABP to IFABP3,4 may cause or be associated with altered lipid

uptake/metabolism and lipid related diseases ’

such as diabetes, atherogenesis, and

body fat increases often seen in old age. LFABP undergoes a conformational change
upon fatty acid binding, changing its structure slightly as the fatty acid is integrated into
the protein6. LFABP levels are known to be gender dependent, with females showing

higher levels than males10. A low amount of LFABP relative to the amount of IFABP
may correspond to a higher level of circulating fatty acids in the bloodstream, which

could in turn contribute to lipid deposition in the blood vessels3,4. Atherosclerosis and

hypertension may develop as a result3, 4. A significant difference of LFABP and IFABP
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level/ratio was seen in different rats of both genders in the previous research in our

laboratory3,4. LFABP has been studied extensively, particularly in rats. Previous research

shows that primary amino acid sequence of rat liver FABP is 82 % homologous to human
liver FABP5 and that rat and human Z protein exhibited similar binding affinities for

various bile acids. It was also shown that administration of different drugs like clofiberate
to rats increases LFABP levels 3’4. It is thought that the increase in levels of FABP is due

to retention of export proteins. LFABP is thought to covalently bond to the drugs, causing

increase in levels of LFABP3,4. The specific mechanism for this process is not known.

1.2 In-House Method

The present in-house method (IHM) to measure fatty acid binding protein in rat
liver at our laboratory was designed over ten years3,4 with several different steps. It is
complex, labor-intensive and takes a whole day’s work (8 hours) to process liver and

intestine samples from one rat. The most recent form of the IHM uses molecular sieve
chromatography to separate a very complex mixture of proteins into simpler mixtures that
allow assessment of the presence and content of LFABP in a test sample of liver cytosol.
The IHM uses Sephadex G-75 polymer matrix in the chromatography column to separate
FABP. The IHM requires 4 grams of tissue to be processed through a column

chromatogram followed by 3 different assays to measure/quantitate LFABP (see section
1.2). The IHM has been used to identify and compare to controls FABPs present and their

levels during life cycle change and as consequences of drug administration3,4,21. The new
method I am seeking to develop to quantitate LFABP by direct measurement of rose
Bengal (RB) absorption in cytosol takes two hours to process and quantitate, using less
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then one gram of tissue. The method is based upon a fluorescence enhancement process
in which the FABP-rose Bengal complex in a sample is exposed to emissions of a 543.5
nm laser and produces a fluorescence spectrum. The new method uses the

spectrochemical perturbation caused by binding of LFABP to rose Bengal dye for direct
measurement of LFABP.
This direct assay method, when perfected, will change the IHM from a complex,

labor-intensive, day long method to one that can be done in approximately two hours. I

found the procedure to be specific for homogenous LFABP (hLFABP). The main

potential interfering proteins in liver, hemoglobin, myoglobin and serum albumin, do not
fluoresce or alter data taken with hLFABP. In addition, examination of LFABPcontaining fractions from Sephadex G-75 shows that they contain about 90% of

fluorescing material and the remainder of the fractions give about 10% as much

fluorescence as seen with LFABP containing fractions. Several samples of cytosol that
contain LFABP in known quantities were used in our new direct assay method and
compared with Sephadex G-75 pool assay. It was seen that the enhancement of the
emission peak was directly proportional to the amount of FABP present in the sample.

The new assay method, when perfected, will facilitate uncovering FABP roles in health
and disease, improving treatment of lipid related human diseases. This process will add to
our ability to study FABPs and can further be used to study IFABP. This approach could

possibly be extended to making a biosensor for detecting liver fatty acid binding proteins.
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CHAPTER 2

OBJECTIVES
The objective is to develop a new method to directly measure LFABP from cytosol.
My work seeks to:

•

Show that rose Bengal absorption enhancement by new method is proportional to
LFABP concentration, with homogenous LFABP.

•

Prove specificity of the LFABP effect by comparing it to hemoglobin, serum
albumin and myoglobin.

•

Demonstrate that cytosol proteins other than FABP do not contribute to the FABP
effect.

•

Show that direct FABP binding in cytosol gives results comparable to the data
obtained with the IHM.
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CHAPTER 3
MATERIALS AND METHODS
3.1 Materials

The following instruments and chemicals were used in preparation of cytosol

from liver, separation of FABP, assays, and direct measurement of FABP.
Instruments
Beckman L5-65B ultracentrifuge (Beckman Coulter, Inc., Palo Alto, CA),
homogenizer apparatus (Arthur H. Thomas, Philadelphia, PA), IEC Centra-B Plus low

speed centrifuge (International Equipment Company, Needham Heights, MA), Mettler
Toledo electronic balance Model # AG104 (Mettler Toledo, Inc., Columbus, OH), Milton
Roy Spectronic Genesys 5 (Milton Roy USA, Ivyland, PA) and Genesys 8 (Spectronic

Instruments, Madison, WI) spectrophotometers, YSI-2700 Select Biochemistry Analyzer
(YSI Life Sciences, Yellow Springs, OH), Ocean Optics spectrometer model #
CHEM2000-UV-VIS (Ocean Optics, Inc., Dunedin, FL), and JDS Uniphase Neon Laser
model # 1674MP (JDS Uniphase Corporation, San Jose, CA).

Solutions and Chemicals
TSM buffer, YSI-2357 buffer (YSI Life Sciences, Yellow Springs, OH),

Sephadex G-75 resin, rose Bengal dye, and dextran-charcoal. The chemicals were

purchased from Sigma-Aldrich Chemical Company (Sigma-Aldrich Corp., St. Louis,
MO) unless otherwise indicated. All solutions are made in deionized water unless noted

otherwise.
9

TSM buffer contains 0.05OM trishydroxymethylaminomethane (tris base), 0.25 M
sucrose, and 3.00 mM 2-mercaptoethanol (pH 7.5). It was the buffer used during all
experiments unless otherwise indicated. It was made in 1 L deionized water as follows:

6.05 g Tris base, 85.5g sucrose and 0.30 ml mercaptoethanol is weighed and added to 750
ml cold deionized water (di-water) and are stirred until they dissolve. The pH of the

solution is measured and is neutralized to pH 7.6, and then 250 ml of di-water is added.

The solution is stirred in a cold box until it is cold, and the pH is checked again and

restandardized if necessary ’

. Sephadex G-75 polymer (Amersham Biosciences,

Piscataway, NJ) was used to separate FABP from other proteins in cytosol by column

chromato graphy3 ’4.

40.0 mM rose Bengal solution was prepared by mixing 41 milligrams of rose
Bengal in one liter of deionized water for the regular assay used in the In House Method

(IHM3,4). The IHM uses 0.30 mL of 40 mM (~11 mM) rose Bengal solution for the assay.
10 mM rose Bengal per liter was prepared in deionized water for the direct assay method.
Rose Bengal for the direct assay is made in YSI-2357 buffer. 13 milligrams YSI-2357

buffer per liter dissolved in deionized water. The use of the dye in all assay methods will
be described in the second section of this chapter.

Dextran-coated charcoal was prepared by diluting 0.828 g of Na2HPO4 (Fisher

Scientific Co., Pittsburgh, PA) with 200 mL of cold (4°C) deionized water and
standardized to a pH of 7.4.

Then, 1.0 g of Dextran T-170 (Fisher Scientific Co.,

Pittsburgh, PA) and 10.0 grams of Norit A decolorizing carbon (Fisher Scientific Co.,

Pittsburgh, PA) were added to the solution. Dextran-coated charcoal was used to remove
rose Bengal dye which did not bind the protein.
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All rats used in these studies were either purchased from Harlan-Sprague Dawley
(Indianapolis, IN), or bred from animals purchased from Harlan-Sprague Dawley. The

strains used were spontaneously hypertensive rats (SHRs) and Holtzman rats. The
breeding and housing of all rats was in the University of Dayton animal facility. Strain
differences, diets, and drugs including clofibrate (Ayerst Laboratories, Collegeville, PA),

and fenofibrate (Abbott Laboratories, North Chicago, IL) were used as described

elsewhere ’ to cause the variations of FABP levels denoted in the results section of this
thesis.

3.2 Routine In-House Method

Sacrificing the Animals and Preparing Cytosol

In this method, devised and refined over ten years in our laboratory3’4, all animals
used were killed by decapitation after their weights were recorded. Then, their livers were

removed, and placed on ice. After weighing each liver, about 4 grams representative

samples were collected. Each sample was homogenized in a glass tube (Potter-Elvhjem
homogenizer Bellco Glass, Inc., Vineland, NJ) with 1 mL of TSM buffer per gram of

tissue3’4. Each homogenate was next poured into a centrifuge tube, placed in a Beckman
fixed-angle 40-centrifuge rotor (Beckman Coulter, Inc., Palo Alto, CA) and centrifuged

(105,000 x g) for 60 minutes at 2° C. After each centrifugation, the supernatant (cytosol)
was separated from the sediment, and its volume was measured and recorded.

Sephadex G-75 Chromatography

A 1.25 x 70 cm column was prepared for use with each cytosol sample prior to
each experiment ’ . The cytosol from one liver sample was pipetted into the top of the

column; the column was run until the sample (cytosol) entered the polymer matrix. 6 ml
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of TSM was added to the column, and a TSM drip was applied to elute the column. A

fraction collector collected sixty aliquots of 1.5 mL (fractions) over 2 to3 hours. All the

proteins are eluted at different times and into different fractions. The tubes were then
assayed to check protein content and LFABP.

FABP Measurement
The fractions collected were subjected to three assays for quantitation. These were
the A-280 column assay for protein content, the A-560 column assay for the LFABP
content and the pool assay which quanitated tissue LFABP content. The A-280 and the

A-560 assays which utilized the fractions collected from G-75 columns will be called
Reference Assays to differentiate them from the pool assay which uses pooled column
fractions shown to contain FABP by the A-560 column assay.

Assay Methods

A-280 Reference Assay: 0.1 mL of sample was removed from chosen fractions

from the G-75 column. They were each mixed with 0.9 mL of ice cold TSM buffer in

separate test tubes and read in the Milton-Roy spectrophotometer at 280 nm. Absorbance
readings were graphed against fraction numbers as shown in Figure 1. The resultant large
peak on the graph represents the majority of non-FABP proteins. The FABPs, which

elute near the end of the chromatogram due to their small size, are found along the

downward slope of the curve.
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Figure 1: 280 nm absorbance from A-280 assay

A-560 Reference Assay: This assay uses the same samples from the column
fractions as the 280 assay. First, 0.1 mL of each sample is mixed with 0.75 mL TSM and
0.3 mL of 40 mM rose Bengal. The mixture was allowed to sit on ice for five minutes.

Then, 0.15 mL of Dextran-charcoal was added and the mixture was kept on ice for eight

minutes.

Next, the samples were centrifuged in Centra-B Plus centrifuge for eight

minutes, and finally the absorbance was measured and graphed as shown in Figure 2.

After graphing the absorbance of 280 nm and 560 nm assays, the results were analyzed.
The 280 nm peak confirmed that there are proteins present. The first 560 nm assay peak
identifies most cell proteins. The second 560 nm peak shows which fractions contain

FABP. The graph is plotted for two different Y-axis because they are read at different

wavelengths and show different absorbance.

13

Figure 2: A-560 assay indicating the fractions containing FABP
Pool Assay (Reference): The fractions that contained FABP were pooled. Five
samples of the pool were then diluted with TSM for assay as shown in Table 1 3’4.

Table 1: Pool Assay to quantitate FABP by IHM
Tube

0

1

2

3

4

5

Number

FABP pool
(ml)

0.000 0.050 0.100 0.200 0.400 0.600

TSM (ml)

0.750 0.700 0.650 0.550 0.450 0.350

Six tubes were filled as shown. Following TSM addition, rose Bengal was added
to each tube, the tubes were vortexed and allowed to stand on ice for 5 minutes, and

Dextran charcoal was added. The mixtures were kept on ice for eight more minutes and

centrifuged in the Centra-B Plus centrifuge for eight minutes. The supernatants were

drawn off and read at 560 nm3,4.
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3.3 Calculations
A series of calculations were used to obtain the amount of FABP in milligrams
per gram liver. First, the absorbance read for the pool assay was divided by the volume of

the pool to obtain absorbance per milliliter.

...
. T
.
Absorbance 560
Absorbance / mL pool =--------------------------Pool volume in sample

Then the readings were averaged, and the total absorbance in the pool (in red

binding units, RBU) was calculated by multiplying the average by 0.67, a factor devised

to correct for changes in assay volumes in 1997 in our laboratory3,4.

Total RBU _ (average RBU/mL) X (Pool Volume)
°3
0.67

The milligrams of FABP per gram tissue was calculated by dividing the total red

binding protein units by 3.69 (the product of assay correction factor 2.86 and 1.29, the
absorption of 1 mg pure LFABP in the assay3,4) and the weight of the tissue
chromatographed.

mg FABP/g liver =

Total RBU
(3.69) X(corrected weight)
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CHAPTER 4
DIRECT ASSAY METHOD
4.1 Experimental Setup for Direct Assay
The assay developed here uses cytosol directly. I am developing this assay in an

effort to replace the much slower, more complicated IHM. This assay uses the YSI-2700
Select Biochemistry Analyzer which is added to an Ocean Optics Spectrometer (model #

CHEM2000-UV-VIS). A JDS Uniphase Neon Laser (model # 1674MP) of wavelength
543.5 nm is used as a light source to produce the emission as shown in Figure 3.

▲

Computer which
contains the ocean
optics spectrometer
connected to YSI2700 through an
optical cable.

Figure 3: Experimental setup for the direct assay

The YSI-2700 Select Biochemistry Analyzer consists of a sampling chamber (400 pL

volume) and a sipper which injects the test solution into the chamber. The sipper injects
25 pL of sample per injection. An optical cable is attached to the sampling chamber at
right angles to the laser beam which is the light source and a quartz mirror is placed
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opposite to the optical cable so any light reflected away from the optical cable is
redirected back to it to provide a strong signal. The optical cable is connected to the

spectrophotometer. Initially the sampling chamber is flushed with 10 mM rose Bengal
dye and the emission peak of the dye is recorded on the computer via the Ocean Optics

software supplied with the spectrophotometer. The analyzer is designed to flush the
chamber three times, every time the flush button is used. Next, cytosol is injected into

the sampling chamber which contains rose Bengal dye and mixed quickly by the

instrument. Liver FABP binds rose Bengal and the change in the emission peak is
recorded by the software. The binding of LFABP and rose Bengal dye enhances the

emission peak height. This process is repeated with several different samples of diluted

cytosol (1:1, 1:3, 1:5, 1:8 and 1:10 dilutions), and the emission peak is recorded for each

sample. All the samples are diluted in TSM buffer. The sampling chamber is flushed with
rose Bengal dye before and after injecting the cytosol because the rose Bengal emission

peak is used as a reference to record the change in emission for different dilutions of
cytosol. The recorded emission peak is plotted on an Excel spreadsheet and the data are
related and compared with the results obtained using the IHM.

4.2 Data Plotting and Calculations
The emission spectrum is recorded and stored on the computer using the Ocean
Optics software. The recoded data can then be opened in an Excel spreadsheet. The data

gives the wavelength from 178 nm to 879 nm and the respective intensity of the emission

peak next to it as shown in the sample data below. The data are plotted using the XY

(scatter) chart type. The emission peak of rose Bengal and the enhanced emission peak
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due to FABP binding are plotted. Then the highest point of both the emission peaks are
recorded and the highest point of the enhanced emission peak is subtracted from the

highest point of the rose Bengal emission peak which gives the actual effect, or effective

peak height, due to the presence of FABP.
The same procedure is repeated for each concentration of FABP or cytosol used

and then the concentration of FABP in the chamber is plotted against the effective peak
height. It was seen that the concentration of FABP was proportional to the enhancement
of the emission peak. The data are shown below in Table 3 and plotted in Figure 4.

Table 2: Sample emission peak data
Intensity (counts)

Wavelength (nm)
178.4

0

228.7

0.90

278.5

-0.90

328.8

-1.4

378.0

0.10

428.7

1.3

478.8

2.9

528.9

7.4

578.8

331

628.8

123

678.5

16
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Table 3: FABP concentration against effective emission peak height
Dilution ratio

[FABP]

Enhanced
Emission Peak

Rose Bengal
Emission Peak

Effective peak
Height

1:1

12.5

602

231

369

1:3

8.3

474

222

251

1:5

5.0

389

232

156

1:10

2.5

318

244

73

[FABP]

Figure 4: Effective emission peak plotted against the FABP concentration
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CHAPTER 5

Results
5.1 Rose Bengal
10 mM rose Bengal was made in YSI-2357 buffer, as explained in Material and

Methods discussion. The rose Bengal solution was connected to a pump which allows the
YSI-2700 Select Bioanalyzer to use it to flush the sampling chamber through a sipper.

The sampling chamber is flushed three times in between uses. The laser and the

equipment are set as explained in Section 2.1. The emission peak of the rose Bengal

solution in the sampling chamber is then recorded on the computer using Ocean Optics

software. The recorded spectral data are then plotted in an Excel spread sheet. The
intensity of the emission is then plotted against the wavelength (e.g. Figure 5).

Figure 5: Emission peak of 10 mM rose Bengal solution
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Different concentrations (10 mM, 20 mM, 50 mM and 100 mM) rose Bengal

solutions were made in YSI-2357 buffer. These solutions were used to flush the sampling
chamber as already explained. The solutions are used one after the other and the emission
peak of each solution is recorded. The data are then stored and plotted in Excel. As

shown in Figure 6, higher concentrations of rose Bengal gave smaller emission peaks

since the solutions were hazy allowing less light to penetrate through to the optical cable.
The results show that 10 mM rose Bengal solution is the optimum concentration to be

used in our direct assay method.

Figure 6: Different concentration of rose Bengal used to check the
concentration which is optimum to use

Initially partial purified LFABP (9.5mg/ml) was used. The LFABP was purified

at Dr. Singer’s laboratory using different chromatography columns [G-75, A-50 and
DEAE-Sephadex A-50 ’ “]. The LFABP was stored in 500 pi aliquots to minimize

FABP breakdown on repeated thawing and freezing. 10 mM rose Bengal solution is used
to flush the sampling chamber and the emission spectrum is recorded. The LFABP
(9.5mg/ml) is placed in the sample holder from which the sipper injects 25 pi samples

into the sampling chamber. The injected LFABP is mixed with the rose Bengal solution
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present in the sampling chamber by a magnetic stirrer. The LFABP binds with rose

Bengal causing an enhancement in the rose Bengal emission peak. The enhanced
emission peak is then recorded and plotted (e.g. Figure 7).

Figure 7: Enhanced emission peak due to binding of 9.5 mg/mL LFABP with 10 mM
rose Bengal solution

Several different concentrations of LFABP (9.5mg/mL, 4.75mg/mL, 2.4mg/mL,

0.95mg/mL, and 0.095mg/mL) were used, consecutively, in the direct assay. Initially 10
mM rose Bengal solution was used to flush the chamber and then 9.5mg/mL LFABP was

injected into the sampling chamber. The emission peak of rose Bengal and the enhanced
emission peak due to LFABP binding with rose Bengal were recorded. The sampling

chamber is always flushed with rose Bengal solution before and after injecting LFABP.
The LFABP concentration cannot be diluted below 0.095mg/mL because at this level no

change in the emission peak occurs. Figure 8 shows that the emission peak ratio, which is
the difference between the emission peak height due to LFABP and rose Bengal divided

by the emission peak ratio of rose Bengal alone shows a linear profile for hLFABP.

Figure 8: Effect of different concentrations of LFABP on the emission peak of
10 mM rose Bengal solution

„ . .
,
.
Enhanced emission peak height due to LFABP- RB binding
AE, Emission peak ratio =----------------------- £-------- ----------------------------------- —
Emission peak height of Rose Bengal alone

To check the specificity of the direct assay method, bovine serum albumin (BSA),

myoglobin and hemoglobin were used in the processes described earlier for FABP. The
serum albumin was used first. lOmM rose Bengal solution is used to flush the sampling

chamber and the emission spectrum was recorded (Figure 9). Then BSA was placed in
the sample holder from which the sipper injects 25 pL samples into the chamber. The
BSA binds rose Bengal causing the emission peak to quench slightly, as shown in Figure

9. The quenched emission peak is then recorded and plotted. Three different

concentrations (0.1 mg/mL, 1 mg/mL and 10 mg/mL) of BSA were used as explained

earlier with LFABP. As shown in Figure 9, 0.1 mg/mL BSA quenches the emission peak
and 10 mg/mL BSA causes both peak shifting and quenching.
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Figure 9: Effect of O.lmg/mL BSA on the emission peak 10 mM rose Bengal

Figure 10: Effects of different concentrations of BSA on the emission peak of
10 mM rose Bengal solution

The same process was repeated for myoglobin and hemoglobin. When 10 mg/ml

myoglobin and hemoglobin was used it was seen that both quench the rose Bengal
emission peak (Figures 11a and lib). The same results were seen with lower

concentrations of myoglobin and hemoglobin. So, all three proteins quenched the

emission peak whereas LFABP enhanced the emission peak.
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(a)

(b)

Figure 11: Effect of 10 mg/ml Myoglobin (a) and Hemoglobin (b) on the emission peak of
10 mM rose Bengal

Next, effects of BSA, myoglobin, and hemoglobin on the enhanced emission due
to presence of LFABP were tested. Initially, 9.5 mg/mL LFABP was injected into the
sampling chamber with help of the sipper and the enhanced emission peak was recorded.

Then we compared this data to those with mixtures of the LFABP and BSA (0.1 mg/ml, 1
mg/ml, and 10 mg/ml). BSA had very little effect on the enhanced emission peak of

LFABP (Figure 12).

Figure 12: Effect of different concentrations of BSA on the enhanced
emission peak of 10 mM rose Bengal
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The same process was repeated to see the effect of different concentrations of

LFABP on the quenched emission peak due to binding of 0.1 mg/mL and 10 mg/mL BSA
with rose Bengal. The results were recorded and plotted as shown in Figure 13. The

figure shows that the presence of 0.1 mg/mL BSA does not cause any effect of the
enhancement of emission peak due to the binding of LFABP with the dye.

Figure 13: Effect of different concentrations of FABP on the quenched
emission peak using 0.1 mg/mL BSA

The process was repeated for lmg/mL and 10 mg/mL BSA with different

concentrations of LFABP. The quenched emission peak due to binding of rose Bengal
dye with 1 mg/mL BSA is used as a control between the different concentrations of

LFABP and similarly for 10 mg/mL BSA. The control is the reference peak. The
presence of 1 mg/mL and 10 mg/mL BSA did not affect the enhancement of the emission

peak as shown for 10 mg/ml BSA in Figure 14.
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Figure 14: Effect of different concentrations of FABP on the quenched
emission peak due to 10 mg/mL BSA

The process was also repeated with myoglobin and hemoglobin to see their effects
on the emission peak of rose Bengal. Once again 0.1 mg/ml, 1 mg/ml, and 10 mg/ml

samples of myoglobin and hemoglobin were compared. As shown in Figures 15 and 16,
myoglobin had no effect on LFABP binding to rose Bengal; LFABP enhanced the

emission peak normally in the presence of myoglobin.

Figure 15: Effect of 10 mg/ml myoglobin on the enhanced emission peak
by 9.5 mg/ml LFABP
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Figure 16: Effect of 9.5 mg/ml LFABP on the quenched emission peak by
10 mg/ml. myoglobin

The experiments shown in Figure 15 and 16 are done one after the other in a short

period of time. The LFABP preparation used in both experiments was the same and the

emissions can be compared. The heights of the enhanced emission peak caused by

LFABP were found to be similar in both cases. The same result was seen in Figure 17

when the process was repeated for hemoglobin.

Figure 17: Effect of 9.5 mg/ml LFABP on the quenched emission peak due to
10 mg/mL hemoglobin
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Table 4: Sample calculation of [FABP] from the graph for myoglobin

FABP concentration
used

9.5 mg/ml

Emission peak
ratio for
Myoglobin
3.08

FABP concentration
calculated from the
graph
9.2 mg/ml

4.75 mg/ml

1.87

4.42 mg/ml

2.375 mg/ml

1.33

2.31 mg/ml

The data of Figures 9 through 17 qualitatively illustrate that the direct assay
method is specific to LFABP, and is not strongly influenced by the presence of other

similar potentially interfering species. The data of these figures can also be investigated

quantitatively using the relation between emission peak ratio and LFABP of Figure 8.
Table 4 compares the known LFABP concentrations with those calculated using
measured emission peak ratios in the presence of myoglobin and the relation between this

parameter and LFABP concentration shown in Figure 8. As this comparison indicates, the

direct assay method provides reasonable estimate of the LFABP concentration.
Next, the samples collected from the column chromatography in our IHM were

used in our direct assay method. As explained previously IHM produces 60 samples of
cytosol eluted from the column. The A-560 assay indicated the tubes which contain the
FABP and tubes that lack FABP as shown in Figure 18. The tubes which contain FABP

and which lack FABP are pooled separately and are used in the direct assay method one
after the other. The YSI-2700 Select Biochemistry Analyzer was then used to study the
emission peak produced by interaction of rose Bengal with LFABP.

It was seen that the FABP in “FABP pool” detected by IHM caused enhanced
emission peak, while the non-FABP containing pool did not enhance the peak (Figure
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19). Since the pool collected from the Sephadex Cr-75 column tubes was dilute, we
concentrated it by 8 fold using an Amicon stirred cell model # 8400 before using it in the

direct assay. The pool lacking FABP contained most other proteins (e.g. serum albumin
and hemoglobin). Myoglobin was present in the pooled FABP-containing fractions.
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Figure 19: Effect of FABP and non-FABP containing pool on the emission peak
of rose Bengal
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In the final step to quantitate LFABP by the direct assay method, cytosol was
used directly. The previous experiments had shown that the direct assay method was

specific for FABP and once the specificity of the assay was clear cytosol was tested in the
direct assay. Cytosol was prepared as explained in Section 1.2. When injected into the

analyzer the LFABP present binds with rose Bengal present in the sampling chamber

causing enhancement in its emission peak (Figure 20). The magnitude of enhancement
depends upon the amount of FABP present in the tissue. Previous research conducted in
"5 1
9I
our laboratory ’ and by others’ showed that animals on special diets like clofiberate and
fenofibrate will have higher amounts of FABP in there tissue hence causing larger

enhancement (Figure 21).

Wavelength (nm)

Figure 20: Effect of cytosol on the emission peak of 10 mM rose Bengal
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Figure 21: Enhanced emission peak of cytosol from animals on different diets

All the animals which were on special diets and the control animals were plotted
against the data take by the IHM. The IHM gives the amount of FABP present per gram

tissue. Figure 21 shows that animals on special diets which have higher amounts of
FABP showed higher effective peak heights and they grouped together while the control

animals which had lower amounts of FABP formed a second group at lower levels.

I
50000
45000

40000
35000
30000
25000
20000
15000
10000
5000

0
0

1.3
2.6
IHM data (mg I7ABP/g)

3.9

Figure 22: IHM data (mg FABP/g tissue) plotted against the effective emission peak
height of the direct assay method
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5.2 Calculations

The effective peak height was calculated as explained in Chapter 2 where the
enhanced emission peak data was separated from the emission peak of rose Bengal to get
the effective emission peak due to the presence of LFABP. The effective emission peak

of LFABP is then multiplied with the dilution ratio and calculated for ImL solution by
multiplying it with 40 since only 25/xL of sample was injected into the sampling

chamber.
Table 5: Effective emission peak height calculated for ImL sample
Dilution ratio

Effective peak height

Effective peak height for ImL

sample

1:2

396.94

396.64x2x40 =31755

1:3

251.89

251.89x 3 x40 = 30226

1:5

156.64

156.64x 5 x40 = 31328

1:10

73.94

73.94x10x40 = 29576

As shown in Table 5 effective peak heights are calculated for different animals.

The effective peak height is then plotted against the IHM data. Table 6 shows the
comparison between the IHM (mg FABP/g tissue) data and the effective peak height
calculated. The data in Table 6 is plotted in Figure 22.
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Table 6: Comparison of IHM with direct assay method

IHM
(mg FABP/g)
data

Effective peak height
for
1 mL sample

0.92

12745

1.02

15240

1.02

17423

1.02

17884

1.02

20867

1.24

19000

1.28

19977

1.29

20307

1.38

21267

2.31

34971

2.31

34537

2.36

35170

2.45

36235

2.46

38176

2.85

39481

2.88

41200
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CHAPTER 6
DISCUSSION
The present study focuses on developing a new assay for measuring fatty acid
binding proteins directly from cytosol. The new method uses the spectrochemical
perturbation that is caused by the binding of LFABP to rose Bengal dye for direct

measurement of LFABP.

The previous research conducted by others6 and our own

IHM3,4 used spectroscopic and binding properties of FABP for identifying and measuring

fatty acid binding proteins in cytosol. In the previous research conducted by others and
our own IHM, the FABP is subjected to chromatography on a Sephadex G-75

equilibrated with buffer. Elution fractions containing FABP are assayed for radioactivity6
and absorbance at 280 nm3, 6 and 560 nm3, 4. Two major peaks are obtained, the second
corresponding to FABP. These methods are complex and labor intensive.
The results of the present study in developing the new assay method aimed to

make the process simple, while obtaining similar results. The new direct assay method

has been tested for specificity for homogenous LFABP3, 4 (hLFABP) and LFABP in
presence of other proteins (non-homogenous). Homogenous LFABP was obtained by

Thomas Burnett in our laboratory3, 4 by applying cytosol to different chromatography
columns (G-75, A-50, and DEAE-Sephadex A-503,4).
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The non-homogenous LFABP is found in cytosol which contains other potential
contaminants3 along with FABP. As shown Figure 7, homogenous LFABP interacts with
rose Bengal dye causing an enhancement in its emission peak. When different
concentrations of hLFABP were used, it was seen (Figure 8) that the response curve was

linear and the new method was able to detect hLFABP within a concentration range from
9.5mg/mL to 0.095mg/mL as evidenced by the change in the enhancement of the
emission peak of rose Bengal. This figure shows that the direct assay method is sensitive

enough to measure FABPs at low concentrations typical of those in the physiological
range.

The direct assay method also shows (Figures 10, 11) that different proteins such
as bovine serum albumin, myoglobin, and hemoglobin do not fluoresce and bind to rose

Bengal, quenching its emission peak. A number of proteins which bind fatty acids and
other organic anions are present in the cytosol out of which serum albumin, myoglobin

and hemoglobin have nucleotide sequence homologies with FABP and have similar
binding properties. Serum albumin is the most abundant protein in the circulatory system

and makes up a large percentage of protein in cytosol. These proteins which are
components of cytosol and their presence may interfere with the assay to quantitate
LFABP if the assay is not specific, as they can interfere with the IHM unless the G-75

chromatogram is carried out. This result shows that these proteins which are components
of cytosol do not cause the same effect as FABP on the emission peak of rose Bengal by
the direct assay method.

The specificity of the assay was determined from results in Figures 14 through 17
which show that the presence of other potential contaminants of cytosol like myoglobin,
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serum albumin, and hemoglobin do not interfere or alter the data taken with hLFABP.
Initially these proteins were tested against the enhanced emission peak of rose Bengal

due to the presence of LFABP, and it was seen that the other proteins had very little
effect on the enhanced emission peak (Figures 12, 15, and 17). Next, LFABP effect on

the quenched emission peak due the presence of proteins like serum albumin, myoglobin,

and hemoglobin was tested. It was seen that the LFABP enhanced the quenched emission

peak normally. These results show that our assay is specific for LFABP.
In the IHM3’ 4 the chromatogram collected from the Sephadex G-75 column

shows (Figure 18) two major emission peaks for the A-560 reference assay. As explained
in Section 1.2 the Sephadex G-75 polymer matrix separates proteins on the basis of
molecular size. The proteins which are of higher molecular size such as serum albumin
and hemoglobin pass around the matrix covering lesser column volume, eluting earlier

than the smaller molecular size proteins such as myoglobin and FABP which elute later2.

The A-560 reference assay uses the relationship between molecular size and elution
behavior of proteins to identify most cell proteins. The first emission peak of the A-560
reference assay corresponds to a molecular mass greater then 60 kDa6 and may reflect the

presence of serum albumin6 and other proteins with fatty acid-binding activity6. The

second peak contains LFABP (Figure 18).

Both the FABP and non-FABP containing samples, as indicated from the
emission peaks of A-560 assay, were pooled and used in the direct assay method. It was
seen (Figure 19) that the pool from the second peak enhanced the emission peak of rose

Bengal indicating the presence of LFABP, while the pool from the first peak did not

enhance the emission peak but shifted it. This indicated the presence of proteins such as
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serum albumin and other potential contaminants of cytosol.

In the final step to quantitate LFABP from cytosol, this cell fraction was directly
used in the direct assay method as shown in Figure 20. It was seen that the cytosol
enhanced the emission peak of rose Bengal; and on the basis of the previous results
(Figures 14 through 17), it was certain that the enhancement caused by the cytosol was

due the presence of FABP. Previous results also show (Figure 19) that the enhancement
of the rose Bengal emission peak is only due to the presence of FABP, while the other

proteins do not enhance the emission peak.
Research conducted previously in our laboratory3, 4 and by others21 showed that
rats on special diets such as clofibrate and fenofibrate show high levels of LFABP

compared with the animals on the normal diet. The cytosol from the animals on special
diets and the normal diet was used in the direct assay method. It was seen (Figure 21) that

the animals on the special diet had larger enhancement of emission peak indicating the

presence of high levels of LFABP, while animals on normal diet had relatively smaller
enhancement of emission peak indicating lower levels of LFABP. This result agrees with
the previous research conducted in our laboratory3,4 and by others21.

In the final stage of my effort to develop this new assay the results from the IHM
were compared to and plotted against the effective peak height due to the presence of
LFABP. The pool assay in the IHM gives the amount of LFABP present per gram of

tissue (Liver) which was plotted against the effective peak height, showing (Figure 22)
that both are directly proportional to each other. It was seen that the data from the IHM

which has higher amount of LFABP present per gram of tissue had higher effective peak
heights while the animals which had lower amount of FABP showed lower effective peak
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heights. All animals on special diets formed a group higher than the control animals

which formed a second lower group. The results plotted in Figure 22 demonstrate the
relation between the direct assay method and the IHM. If we get similar results in both

the methods then the data from IHM (i.e. mg FABP/g tissue) should be directly

proportional to the effective emission peak in the direct assay method, which means
linear data. Some points in the study show variation from linearity, which means that
similar results were not always obtained for the direct assay method and the IHM.
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CHAPTER 7

CONCLUSION AND RECOMMENDATIONS
The direct assay method, when perfected, will facilitate uncovering FABP roles in

health and disease, improving treatment of lipid related human diseases. This process will
add to our ability to study FABPs and can be used to study IFABP further. These studies,

in the future may extended to make biosensors to detect fatty acid binding proteins. The
direct assay method is 10 times faster than the IHM and uses less tissue. The new direct
assay method can be applied to beef liver FABP to see if similar results are obtained.

While the direct assay method is promising, it will need future work to perfect it.
It is recommended that direct assay method can be improved by using a
spectrophotometer to replace our present experimental setup. It is also suggested that
larger sample size of cytosol or LFABP may decrease the error see in the result where the

data for the direct assay method is compared with the IHM. The direct assay method can
be future be improved by understanding the stoichiometry of the reaction taking place

between the FABP and rose Bengal dye. The use of sol-gel slides will help in
understanding the interactions between the rose Bengal and FABP better if the solution

can be kept cold for long periods of time.
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